148 related articles for article (PubMed ID: 31974520)
21. Water-soluble amphotericin B-polyvinylpyrrolidone complexes with maintained antifungal activity against Candida spp. and Aspergillus spp. and reduced haemolytic and cytotoxic effects.
Charvalos E; Tzatzarakis MN; Van Bambeke F; Tulkens PM; Tsatsakis AM; Tzanakakis GN; Mingeot-Leclercq MP
J Antimicrob Chemother; 2006 Feb; 57(2):236-44. PubMed ID: 16361329
[TBL] [Abstract][Full Text] [Related]
22. Antifungal effect of Hevea brasiliensis latex with various fungi. Its synergistic action with amphotericin B against Candida albicans.
Giordani R; Regli P; Buc J
Mycoses; 2002 Dec; 45(11-12):476-81. PubMed ID: 12472724
[TBL] [Abstract][Full Text] [Related]
23. Polyketide derivatives from a marine-sponge-associated fungus Pestalotiopsis heterocornis.
Lei H; Lin X; Han L; Ma J; Dong K; Wang X; Zhong J; Mu Y; Liu Y; Huang X
Phytochemistry; 2017 Oct; 142():51-59. PubMed ID: 28675830
[TBL] [Abstract][Full Text] [Related]
24. In vitro antifungal activities of amphotericin B in combination with acteoside, a phenylethanoid glycoside from Colebrookea oppositifolia.
Ali I; Sharma P; Suri KA; Satti NK; Dutt P; Afrin F; Khan IA
J Med Microbiol; 2011 Sep; 60(Pt 9):1326-1336. PubMed ID: 21474610
[TBL] [Abstract][Full Text] [Related]
25. New potentiators of amphotericin B activity, shodoamides A to C produced by Pseudophialophora sp. BF-0158.
Yagi A; Kashima M; Ishijima H; Tomoda H; Uchida R
J Antibiot (Tokyo); 2023 Oct; 76(10):579-584. PubMed ID: 37479741
[TBL] [Abstract][Full Text] [Related]
26. In vitro activity of antifungal combinations against Candida albicans biofilms.
Tobudic S; Kratzer C; Lassnigg A; Graninger W; Presterl E
J Antimicrob Chemother; 2010 Feb; 65(2):271-4. PubMed ID: 19996142
[TBL] [Abstract][Full Text] [Related]
27. [Short communication: In vitro activity of amphotericin B with fluconazole or voriconazole combinations against Candida albicans isolates].
Oz Y; Akşit F; Kiraz N; Kiremitçi A
Mikrobiyol Bul; 2008 Jan; 42(1):149-55. PubMed ID: 18444574
[TBL] [Abstract][Full Text] [Related]
28. Gilvocarcin HE: a new polyketide glycoside from Streptomyces sp.
Hou J; Liu P; Qu H; Fu P; Wang Y; Wang Z; Li Y; Teng X; Zhu W
J Antibiot (Tokyo); 2012 Oct; 65(10):523-6. PubMed ID: 22854339
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and biological evaluation of nectriatide derivatives, potentiators of amphotericin B activity.
Nagai K; Kobayashi K; Miyake R; Sato Y; Seki R; Fukuda T; Yagi A; Uchida R; Ohshiro T; Tomoda H
J Antibiot (Tokyo); 2024 Apr; 77(4):214-220. PubMed ID: 38267575
[TBL] [Abstract][Full Text] [Related]
30. Tensidols, new potentiators of antifungal miconazole activity, produced by Aspergillus niger FKI-2342.
Fukuda T; Hasegawa Y; Hagimori K; Yamaguchi Y; Masuma R; Tomoda H; Omura S
J Antibiot (Tokyo); 2006 Aug; 59(8):480-5. PubMed ID: 17080684
[TBL] [Abstract][Full Text] [Related]
31. Interactions between amphotericin B and nitroimidazoles against Candida albicans.
Cury AE; Hirschfeld MP
Mycoses; 1997 Oct; 40(5-6):187-92. PubMed ID: 9476486
[TBL] [Abstract][Full Text] [Related]
32. Eurysterols A and B, cytotoxic and antifungal steroidal sulfates from a marine sponge of the genus Euryspongia.
Boonlarppradab C; Faulkner DJ
J Nat Prod; 2007 May; 70(5):846-8. PubMed ID: 17378608
[TBL] [Abstract][Full Text] [Related]
33. Funicone-related compounds, potentiators of antifungal miconazole activity, produced by Talaromycesflavus FKI-0076.
Arai M; Tomoda H; Okuda T; Wang H; Tabata N; Masuma R; Yamaguchi Y; Omura S
J Antibiot (Tokyo); 2002 Feb; 55(2):172-80. PubMed ID: 12002999
[TBL] [Abstract][Full Text] [Related]
34. Enhanced antifungal effects of amphotericin B-TPGS-b-(PCL-ran-PGA) nanoparticles in vitro and in vivo.
Tang X; Zhu H; Sun L; Hou W; Cai S; Zhang R; Liu F
Int J Nanomedicine; 2014; 9():5403-13. PubMed ID: 25473279
[TBL] [Abstract][Full Text] [Related]
35. The in vitro effects of interferon-gamma, alone or in combination with amphotericin B, tested against the pathogenic fungi Candida albicans and Aspergillus fumigatus.
El-Khoury M; Ligot R; Mahoney S; Stack CM; Perrone GG; Morton CO
BMC Res Notes; 2017 Aug; 10(1):364. PubMed ID: 28764751
[TBL] [Abstract][Full Text] [Related]
36. Genome-based mining of new antimicrobial meroterpenoids from the phytopathogenic fungus Bipolaris sorokiniana strain 11134.
Han J; Zhang J; Song Z; Zhu G; Liu M; Dai H; Hsiang T; Liu X; Zhang L; Quinn RJ; Feng Y
Appl Microbiol Biotechnol; 2020 May; 104(9):3835-3846. PubMed ID: 32215711
[TBL] [Abstract][Full Text] [Related]
37. Invitro antifungal susceptibilities of Candida species to liposomal amphotericin B, determined using CLSI broth microdilution, and amphotericin B deoxycholate, measured using the Etest.
Lovero G; Giglio O; Rutigliano S; Diella G; Caggiano G; Montagna MT
J Med Microbiol; 2017 Mar; 66(2):213-216. PubMed ID: 27959780
[TBL] [Abstract][Full Text] [Related]
38. Linolenic acid-modified MPEG-PEI micelles for encapsulation of amphotericin B.
Xu H; Teng F; Zhou F; Zhu L; Wen Y; Feng R; Song Z
Future Med Chem; 2019 Oct; 11(20):2647-2662. PubMed ID: 31621420
[No Abstract] [Full Text] [Related]
39. Allicin enhances the oxidative damage effect of amphotericin B against Candida albicans.
An M; Shen H; Cao Y; Zhang J; Cai Y; Wang R; Jiang Y
Int J Antimicrob Agents; 2009 Mar; 33(3):258-63. PubMed ID: 19095412
[TBL] [Abstract][Full Text] [Related]
40. Antifungal drug susceptibility of oral Candida albicans isolates may be associated with apoptotic responses to Amphotericin B.
Yang C; Gong W; Lu J; Zhu X; Qi Q
J Oral Pathol Med; 2010 Feb; 39(2):182-7. PubMed ID: 19656268
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
